期刊文献+

参七散对2型糖尿病并脂代谢紊乱的影响

Effects of Shenqi Powder on Lipid Metabolism in Patients with Type 2 Diabetes Mellitus
下载PDF
导出
摘要 目的:观察参七散对2型糖尿病并脂代谢紊乱的影响。方法:将148例2型糖尿病肥胖患者分为2组。治疗组予参七散(组成:西洋参、三七)治疗,每天1剂,水煎服。对照组给予非诺贝特胶囊治疗。均治疗8周。观察血清甘油三酯(TG)、糖化血红蛋白(HbA1c)、空腹血糖(FBG)及餐后2h血糖(P2hBG)、体重指数(BM)I。结果:2组治疗后在FBG、P2hBG、TG、BMI等方面均有明显改善,与治疗前比较,差异有显著性或非常显著性意义(P<0.05,P<0.01);2组治疗8周后,治疗组FBG、P2hBG、BMI 3项指标与对照组比较,差异均有显著性意义(P<0.05)。结论:参七散治疗2型糖尿病疗效肯定。 Objective: To investigate the effect of Shenqi Powder on lipid metabolism in patients with type 2 diabetes mellitus. Methods: One hundred and forty-eight patients with type 2 diabetes mellitus were divided into Shenqi Powder group(n=72) and Fenofibrate dispersible tablets group(n=76). Shenqi Powder is composed of Radix Panacis Quinquefolii and Radix Notoginseng, and was used in decoction, one dose per day. All patients were treated for 8 weeks. Triglyceride(TG), Hemoglobin A, glycosylated hemoglobin(HbAlc), fasting blood glucose(FBG), 2-hour postprandial blood glucose(P2hBG), and body mass index(BMI) were observed. Results: FBG, P2hBG, TG and BMI in both groups were improved after treatment(P 〈 0.05compared with those before treatment).The differences of FBG, P2hBG and BMI between the two groups after treatment were significant (P 〈 0.05). Conclusion: Shenqi Powder can effectively decrease BMI, TG and blood glucose levels.
机构地区 汕头市中医医院
出处 《新中医》 CAS 北大核心 2011年第12期38-39,共2页 New Chinese Medicine
基金 2009年汕头市科技局重点科研项目(编号:F200900160)
关键词 2型糖尿病 脂肪代谢 中医疗法 参七散 Type 2 Diabetes Mellitus Lipid Metabolism TCM Therapy Shenqi Powder
  • 相关文献

参考文献9

二级参考文献21

  • 1刘明,董超仁,苏静怡.一种简便实用的大鼠高脂血症模型[J].中国药理学通报,1989,5(2):119-121. 被引量:169
  • 2杨裕国,林东平,盛宏光,姚丕颖.降脂药物── 必降脂对糖代谢的影响[J].中华内分泌代谢杂志,1998,14(2):103-105. 被引量:29
  • 3中华人民共和国卫生部.药物临床研究指导原则[M].,1988.99-102.
  • 4Levy RI. Causes of the decrease in cardiovascular mortality[J]. Am J Cardiol,1984,54(5):7C-13C.
  • 5Brand D. Report of the national cholesterol education program expert panel on detection,evaluation,and treatment of high blood cholesterol in adults[J].Arch Intern Med,1998,148:36-49.
  • 6Acton SL, Kozarsky KF. The HDL receptor SR-B1:a new therapeutic target for atherosclerosis [J].Mol Med Today,1999,5(12):518-524.
  • 7Rosenfalck AM,Thorsby P,Kjems L.Improved postprandial glyeaemic controlswith insulin Aspoirt in type 2 diabetes patients treated with insulin[J].Acta Diabetoligica,2000,37(1):41-46.
  • 8Vladimir V.Konjac-mannan and American ginsing:emerging alternative therapies for type 2 diabetes mellitus[J].J Ame Coll Nutr,2001,20(5):370-380.
  • 9Xie JT,Wu JA,Mehenda HS.Antihyperglycemic effevt of the polysaccharides fraction from American ginseng berry extract in ob/ob mice[J].Phytomedicine,2004,11(2):182-187.
  • 10Brown Get al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels d apoliporotein B.N Engl J Med 1990; 323:1289.

共引文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部